This article has been updated to include a statement from Illumina.
NEW YORK (GenomeWeb News) - Life Technologies and several co-plaintiffs this week filed suit against Illumina for allegedly infringing three DNA-amplification patents.
The suit, filed in the US District Court for the District of Delaware, claims that Illumina and Solexa, which Illumina acquired in 2007, infringe US Patent Nos. 5,616,478; 5,989,698; and 6,001,568. All three patents relate to amplifying nucleic acids in a solid medium.